Showing posts with label Osteoporosis Drugs Market Demand. Show all posts
Showing posts with label Osteoporosis Drugs Market Demand. Show all posts

Asia-Pacific Osteoporosis Drugs Market To Prosper in Coming Years

The osteoporosis drugs market is observing the trend of increasing awareness about the disease and its possible management and treatment methods. With the rising incidence of osteoporosis, many organizations are focusing on creating awareness among the masses regarding it via various campaigns and programs. For instance, the International Osteoporosis Foundation has tasked itself with making people aware about the disease as well as bone health. For the same purpose, Nestlé partnered with the foundation to spread awareness about the preventive measures for osteoporosis.



The major factor contributing to the growth of the osteoporosis drugs market is rapid urbanization, leading to drastic changes in the environment and people’s lifestyle. As per the World Health Organization figures, currently over 50.0% of the world’s population resides in urban areas, which is expected to grow to 70.0% by 2050. Urbanization at such a large scale has left a negative impact on the environment, as a result, affecting people’s health. Unhealthy habits, such as inadequate physical activity, smoking, tobacco and alcohol consumption, and low calcium diet, also affect the bone health.


The osteoporosis drugs market is witnessing growth due to another major factor, i.e. the rising osteoporosis prevalence in post-menopausal women. In women, bone growth is influenced by estrogen, a key hormone in their body. The rapid decline of estrogen in post-menopausal women causes increased bone resorption without an increase in bone formation, which eventually results in decreased bone strength and bone loss. The International Osteoporosis Foundation reported that post-menopausal women are susceptible to fragility fractures, and one in three such women may suffer from fracture once in their lifetime.

Hence, with more people falling prey to this degenerative disease, the market for osteoporosis drugs would continue to flourish.
Share:

Popular Posts